Abstract:Depression is an important morbidity associated with stroke that impacts on recovery yet often undetected or inadequately treated. This is an update and expansion of a Cochrane Review first published in 2004 and updated in 2008. Primary objective • To determine whether pharmacological therapy, non‐invasive brain stimulation, psychological therapy, or combinations of these interventions reduce the prevalence of diagnosable depression after stroke Secondary objectives • To determine whether pharmacological therapy, non‐invasive brain stimulation, psychological therapy, or combinations of these interventions reduce levels of depressive symptoms, improve physical and neurological function and health‐related quality of life, and reduce dependency after stroke • To assess the safety of and adherence to such treatments We searched the Specialised Registers of Cochrane Stroke and Cochrane Depression Anxiety and Neurosis (last searched August 2018), the Cochrane Central Register of Controlled Trials (CENTRAL; 2018, Issue 1), in the Cochrane Library, MEDLINE (1966 to August 2018), Embase (1980 to August 2018), the Cumulative Index to Nursing and Alllied Health Literature (CINAHL) (1982 to August 2018), PsycINFO (1967 to August 2018), and Web of Science (2002 to August 2018). We also searched reference lists, clinical trial registers (World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) to August 2018; ClinicalTrials.gov to August 2018), and conference proceedings, and we contacted study authors. Randomised controlled trials comparing (1) pharmacological interventions with placebo; (2) one of various forms of non‐invasive brain stimulation with sham stimulation or usual care; (3) one of various forms of psychological therapy with usual care and/or attention control; (4) pharmacological intervention and various forms of psychological therapy with pharmacological intervention and usual care and/or attention control; (5) non‐invasive brain stimulation and pharmacological intervention with pharmacological intervention and sham stimulation or usual care; (6) pharmacological intervention and one of various forms of psychological therapy with placebo and psychological therapy; (7) pharmacological intervention and non‐invasive brain stimulation with placebo plus non‐invasive brain stimulation; (8) non‐invasive brain stimulation and one of various forms of psychological therapy versus non‐invasive brain stimulation plus usual care and/or attention control; and (9) non‐invasive brain stimulation and one of various forms of psychological therapy versus sham brain stimulation or usual care plus psychological therapy, with the intention of treating depression after stroke. Two review authors independently selected studies, assessed risk of bias, and extracted data from all included studies. We calculated mean difference (MD) or standardised mean difference (SMD) for continuous data, and risk ratio (RR) for dichotomous data, with 95% confidence intervals (CIs). We assessed heterogeneity using the I2 statistic and certainty of the evidence according to GRADE. We included 49 trials (56 comparisons) with 3342 participants. Data were available for: (1) pharmacological interventions with placebo (with 20 pharmacological comparisons); (2) one of various forms of non‐invasive brain stimulation with sham stimulation or usual care (with eight non‐invasive brain stimulation comparisons); (3) one of various forms of psychological therapy with usual care and/or attention control (with 16 psychological therapy comparisons); (4) pharmacological intervention and various forms of psychological therapy with pharmacological intervention and usual care and/or attention control (with two comparisons); and (5) non‐invasive brain stimulation and pharmacological intervention with pharmacological intervention and sham stimulation or usual care (with 10 comparisons). We found no trials for the following comparisons: (6) pharmacological intervention and various forms of psychological therapy interventions versus placebo and psychological therapy; (7) pharmacological intervention and non‐invasive brain stimulation versus placebo plus non‐invasive brain stimulation; (8) non‐invasive brain stimulation and one of various forms of psychological therapy versus non‐invasive brain stimulation plus usual care and/or attention control; and (9) non‐invasive brain stimulation and one of various forms of psychological therapy versus sham brain stimulation or usual care plus psychological therapy. Treatment effects observed: very low‐certainty evidence from eight trials suggests that pharmacological interventions decreased the number of people meeting study criteria for depression (RR 0.70, 95% CI 0.55 to 0.88; 1025 participants) at end of treatment, and very low‐certainty evidence from six trials suggests that pharmacological interventions decreased the number of pe -Abstract Truncated-

Non-pharmacological interventions to treat mood disturbances post-stroke: a systematic review

Effectiveness of non-pharmacological interventions for treating post-stroke depressive symptoms: Systematic review and meta-analysis of randomized controlled trials

The Efficacy of Therapies for Post-Stroke Depression in Aging: an Umbrella Review.

Psychological interventions for mood and cognition after stroke and transient ischaemic attack: A protocol for an umbrella review

Poststroke Depression and Risk of Stroke Recurrence and Mortality: Protocol of a Meta-Analysis and Systematic Review

A systematic review of rehabilitation interventions to prevent and treat depression in post-stroke aphasia

Effectiveness of non-pharmacological therapies for treating post-stroke depression: A systematic review and network meta-analysis

Pharmacological, psychological, and non-invasive brain stimulation interventions for treating depression after stroke.

What are the effects of pharmacological, non-invasive brain stimulation and psychological interventions, and their combination, in the treatment of post-stroke depression? A Cochrane Review summary with commentary

Systematic Hypothesis for Post-Stroke Depression Caused Inflammation and Neurotransmission and Resultant on Possible Treatments.

Effect of behavioural activation for individuals with post-stroke depression: systematic review and meta-analysis

Addressing cognitive impairment following stroke: systematic review and meta-analysis of non-randomised controlled studies of psychological interventions

Non-pharmacological therapies for the management of the cognitive dysfunctions in post-stroke patients: a systematic review and network meta-analysis

(Neuro)Psychological Interventions for Non-Motor Symptoms in the Treatment of Patients with Parkinson’s Disease: a Systematic Umbrella Review

Effect of nonpharmacological interventions on poststroke depression: a network meta-analysis

Effects of non-pharmacological interventions on fatigue in people with stroke: a systematic review and meta-analysis

Effectiveness of Psychological Intervention on Post-stoke Depression:A Systematic Review

Review on stroke induced depression

Nonpharmacological therapies for central poststroke pain: A systematic review

Effects of home-based exercise interventions on post-stroke depression: A systematic review and network meta-analysis

Cognitive behavioural therapy for depression, quality of life, and cognitive function in the post‐stroke period: systematic review and meta‐analysis